Cartesian Therapeutics grants new employee option to buy 50,000 shares
RNAC•Cartesian Therapeutics granted a new employee an option to purchase 50,000 common shares at an exercise price of $6.34, with a 10-year term.
1. Option terms
The option was granted on November 2, 2026. Vesting begins at 25% on November 2, 2027, followed by 36 substantially equal monthly installments through November 2, 2030.
